CLINICAL_TRIALS
trial_result
· 2019-05-15
Clinical Trial Update: Smoking Relapse Prevention Among COPD Ex-smokers [Phase 3]
Summary
Phase 3 trial on smoking relapse prevention among COPD ex-smokers was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Auckland, New Zealand | Conditions: Chronic Obstructive Pulmonary Disease, Smoking Cessation | Phase 3 | Status: TERMINATED